Shenzhen Weiguang Biological Products Co Ltd (002880) - Total Liabilities

Latest as of March 2026: CN¥1.19 Billion CNY ≈ $174.34 Million USD

Based on the latest financial reports, Shenzhen Weiguang Biological Products Co Ltd (002880) has total liabilities worth CN¥1.19 Billion CNY (≈ $174.34 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 002880 net assets growth trend to track the company's year-over-year net asset growth rate.

Shenzhen Weiguang Biological Products Co Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Shenzhen Weiguang Biological Products Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Shenzhen Weiguang Biological Products Co (002880) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Shenzhen Weiguang Biological Products Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shenzhen Weiguang Biological Products Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
President Bakery Public Company Limited BK:PB	Thailand	฿1.13 Billion
Reitir fasteignafélag hf IC:REITIR	Iceland	Ikr174.57 Billion
Beijing SPC Environment Protection Tech Co Ltd SHE:002573	China	CN¥16.85 Billion
Yuanli Chemical Group Co Ltd SHG:603217	China	CN¥1.55 Billion
Mingchen Health Co Ltd Class A SHE:002919	China	CN¥460.97 Million
Sichuan Huiyu Pharmaceutical Co Ltd SHG:688553	China	CN¥1.16 Billion
Hunan Yussen Energy Technology SHE:002986	China	CN¥5.71 Billion
Shanghai Weihong Electronic Technology Co Ltd SHE:300508	China	CN¥297.91 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Shenzhen Weiguang Biological Products Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 002880 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shenzhen Weiguang Biological Products Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shenzhen Weiguang Biological Products Co Ltd (2012–2025)

The table below shows the annual total liabilities of Shenzhen Weiguang Biological Products Co Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.29 Billion ≈ $189.49 Million	+22.95%
2024-12-31	CN¥1.05 Billion ≈ $154.12 Million	+26.72%
2023-12-31	CN¥831.14 Million ≈ $121.62 Million	+17.36%
2022-12-31	CN¥708.20 Million ≈ $103.63 Million	+229.04%
2021-12-31	CN¥215.23 Million ≈ $31.49 Million	+1.35%
2020-12-31	CN¥212.36 Million ≈ $31.08 Million	+55.42%
2019-12-31	CN¥136.64 Million ≈ $19.99 Million	-11.00%
2018-12-31	CN¥153.53 Million ≈ $22.47 Million	-10.49%
2017-12-31	CN¥171.52 Million ≈ $25.10 Million	-57.48%
2016-12-31	CN¥403.44 Million ≈ $59.04 Million	-12.72%
2015-12-31	CN¥462.25 Million ≈ $67.64 Million	+0.33%
2014-12-31	CN¥460.73 Million ≈ $67.42 Million	-5.76%
2013-12-31	CN¥488.91 Million ≈ $71.54 Million	-7.86%
2012-12-31	CN¥530.63 Million ≈ $77.65 Million	--

About Shenzhen Weiguang Biological Products Co Ltd

SHE:002880 China Biotechnology

Market Cap

$672.72 Million

CN¥4.60 Billion CNY

Market Cap Rank

#10671 Global

#2866 in China

Share Price

CN¥20.27

Change (1 day)

+0.45%

52-Week Range

CN¥18.80 - CN¥31.04

All Time High

CN¥963796.17